Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Universal Health Realty Income Trust (UHT) Shares Outstanding (Diluted Average) (2016 - 2026)

Universal Health Realty Income Trust has reported Shares Outstanding (Diluted Average) over the past 16 years, most recently at $13.9 million for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 37370.27% to $13.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.9 million through Dec 2025, up 37370.27% year-over-year, with the annual reading at $13.9 million for FY2025, 37370.27% up from the prior year.
  • Shares Outstanding (Diluted Average) was $13.9 million for Q4 2025 at Universal Health Realty Income Trust, roughly flat from $13.9 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $13.9 million in Q4 2025 and troughed at $13771.0 in Q1 2021.
  • The 5-year median for Shares Outstanding (Diluted Average) is $13.8 million (2022), against an average of $9.0 million.
  • Year-over-year, Shares Outstanding (Diluted Average) tumbled 99.84% in 2021 and then surged 100074.2% in 2022.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $22000.0 in 2021, then grew by 9.09% to $24000.0 in 2022, then increased by 16.67% to $28000.0 in 2023, then soared by 32.14% to $37000.0 in 2024, then soared by 37370.27% to $13.9 million in 2025.
  • Per Business Quant, the three most recent readings for UHT's Shares Outstanding (Diluted Average) are $13.9 million (Q4 2025), $13.9 million (Q3 2025), and $13.9 million (Q2 2025).